Literature DB >> 33510806

Involvement of Muscarinic Receptors in Hypotensive and Diuretic Effects of Aqueous Soluble Fraction from Asphodelus tenuifolius Cav.

Waqas Younis1,2, V B Schini-Kerth3, Samara Requena Nocchi4, Denise Brentan Silva4, Priscila de Souza5, Ishfaq Ali Bukhari6, Fahim Vohra7, Sibtain Afzal8, Arquimedes Gasparotto Junior9.   

Abstract

Background. Asphodelus tenuifolius Cav. (Asphodelaceae) is widely used in Pakistan traditional medicine as a hypotensive and diuretic agent. Despite the cardioprotective effects described for A. tenuifolius, the mechanisms involved in its probable hypotensive and diuretic effects have never been evaluated. Firstly, different extracts from A. tenuifolius seeds were obtained, and their antioxidant profiles and chemical constituents by LC-DAD-were determined, including molecular networking by the GNPS platform. Then, to evaluate changes in blood pressure, different groups of anesthetized normotensive rats were intravenously treated with the crude extract (AT-Cr, 1-50 mg/kg), aqueous (AS-AT, 1-25 mg/kg), n-butanol (BS-AT, 1-50 mg/kg), and dichloromethane fraction (DS-AT, 1-80 mg/kg). The diuretic effects of AT-Cr, AS-AT, BS-AT, and DS-AT at 100, 200, and 300 mg/kg, p.o. doses, were also evaluated in comparison with hydrochlorothiazide (HCTZ, 10 mg/kg, p.o). The urinary volume, sodium, potassium, and pH were estimated in the sample collected for 6 h from saline-loaded rats. Using pharmacological antagonists or inhibitors, we determine the involvement of acetylcholine, prostaglandins, and nitric oxide in A. tenuifolius-induced hypotensive and diuresis action. In addition, the activities of angiotensin-converting enzyme, erythrocyte carbonic anhydrase, and renal Na+/K+/ATPase were evaluated in vitro. Acute treatment with crude extract and fractions of A. tenuifolius exhibited significant hypotensive and diuretic potential in normotensive rats. However, AS-AT produced the most potent and significant dose-dependent hypotension and diuretic effects in normotensive rats. Previous treatment with atropine significantly reduced the hypotensive and diuretic action of AS-AT, but pretreatment with indomethacin or L-NAME did not affect these effects. Moreover, the 7-day treatment with AS-AT did not reduce activities of serum angiotensin-converting enzyme, erythrocyte carbonic anhydrase, and renal Na+/K+/ATPase. AS-AT showed four major compound node clusters, which included sugars, alkaloids, nucleoside, amino acid, and glycosylated flavonoids. This research supports and extends the traditional use of A. tenuifolius as a hypotensive and diuretic agent. The results showed that AS-AT from A. tenuifolius could present compounds responsible for hypotensive and diuretic activities through the activation of muscarinic receptors.
Copyright © 2021 Waqas Younis et al.

Entities:  

Year:  2021        PMID: 33510806      PMCID: PMC7822673          DOI: 10.1155/2021/6653270

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  40 in total

1.  Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme.

Authors:  Arquimedes Gasparotto Junior; Francielly Mourão Gasparotto; Emerson Luiz Botelho Lourenço; Sandra Crestani; Maria Elida Alves Stefanello; Marcos José Salvador; José Eduardo da Silva-Santos; Maria Consuelo Andrade Marques; Cândida Aparecida Leite Kassuya
Journal:  J Ethnopharmacol       Date:  2010-12-24       Impact factor: 4.360

Review 2.  Cellular and Molecular Mechanisms of Diuretic Plants: An Overview.

Authors:  Francislaine Aparecida Livero; Jacqueline Vergutz Menetrier; Emerson Luiz Botelho Lourenco; Arquimedes Gasparotto Junior
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 3.  The carbonic anhydrases: widening perspectives on their evolution, expression and function.

Authors:  R E Tashian
Journal:  Bioessays       Date:  1989-06       Impact factor: 4.345

Review 4.  The Kidney in Hypertension.

Authors:  Hillel Sternlicht; George L Bakris
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

5.  Endothelium-independent vasorelaxant effect of Asphodelus tenuifolius Cav. via inhibition of myosin light chain kinase activity in the porcine coronary artery.

Authors:  Waqas Younis; V B Schini-Kerth; Arquimedes Gasparotto Junior; Samara Requena Nocchi; Denise Brentan Silva; Richard E Roberts
Journal:  J Ethnopharmacol       Date:  2020-12-14       Impact factor: 4.360

6.  Two new stilbene dimer glucosides from grape (Vitis vinifera) cell cultures.

Authors:  P Waffo-Teguo; D Lee; M Cuendet; J Mérillon; J M Pezzuto; A D Kinghorn
Journal:  J Nat Prod       Date:  2001-01       Impact factor: 4.050

7.  ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.

Authors:  T O Morgan; A I Anderson; R J MacInnis
Journal:  Am J Hypertens       Date:  2001-03       Impact factor: 2.689

8.  A method for screening diuretic agents in the rat.

Authors:  S T Kau; J R Keddie; D Andrews
Journal:  J Pharmacol Methods       Date:  1984-03

9.  Systematic characterization of the chemical constituents in vitro and prototypes in vivo of Dingkun Dan using ultra-high-performance liquid chromatography quadrupole time-of-flight mass spectrometry combined with the UNIFI™ software.

Authors:  Xiu-Xiu Dou; Shan Lin; Xin-Hui Tian; Yu-Hao Zhang; Xin Guo; Ji Ye; Wei-Dong Zhang
Journal:  Biomed Chromatogr       Date:  2020-07-29       Impact factor: 1.902

10.  Celosia argentea L. (Amaranthaceae) a vasodilator species from the Brazilian Cerrado - An ethnopharmacological report.

Authors:  Sara Emilia Lima Tolouei; Cleide Adriane Signor Tirloni; Rhanany Alan Calloi Palozi; Maysa Isernhagen Schaedler; Lucas Pires Guarnier; Aniely Oliveira Silva; Valter Paes de Almeida; Jane Manfron Budel; Roosevelt Isaias Carvalho Souza; Ariany Carvalho Dos Santos; Vanessa Samúdio Dos Santos; Denise Brentan Silva; Paulo Roberto Dalsenter; Arquimedes Gasparotto Junior
Journal:  J Ethnopharmacol       Date:  2018-09-21       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.